DOCSLIB.ORG

Genetic Alterations of Multiple Tumor Suppressors and Oncogenes in the Carcinogenesis and Progression of Lung Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic Alterations of Multiple Tumor Suppressors and Oncogenes in the Carcinogenesis and Progression of Lung Cancer Oncogene (2002) 21, 7421 – 7434 ª 2002 Nature Publishing Group All rights reserved 0950 – 9232/02 $25.00 www.nature.com/onc Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer Hirotaka Osada1 and Takashi Takahashi*,1 1Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan Lung cancer has become the leading cause of cancer number of deaths. Multiple morphological steps have death in many economically well-developed countries. been recognized in the carcinogenic process of lung Recent molecular biological studies have revealed that cancer. In the development of squamous carcinoma at overt lung cancers frequently develop through sequential the bronchial epithelium, oncogenic triggering converts morphological steps, with the accumulation of multiple normal bronchial epithelium into hyperplastic, meta- genetic and epigenetic alterations affecting both tumor plastic and dysplastic lesions. After these premalignant suppressor genes and dominant oncogenes. Cell cycle stages, lung cancer develops as a carcinoma in situ progression needs to be properly regulated, while cells (CIS), and then emerges as an overt squamous cell have built-in complex and minute mechanisms such as carcinoma. Adenocarcinoma is also considered to cell cycle checkpoints to maintain genomic integrity. develop at least in part from premalignant precursor Genes in the p16INK4A-RB and p14ARF-p53 pathways lesions such as atypical adenomatous hyperplasia appear to be a major target for genetic alterations (AAH). Molecular biological studies have demon- involved in the pathogenesis of lung cancer. Several strated that overt cancers carry multiple genetic and oncogenes are also known to be altered in lung cancer, epigenetic alterations, indicating inactivation of tumor leading to the stimulation of autocrine/paracrine loops suppressor genes and activation of dominant onco- and activation of multiple signaling pathways. It is genes during the processes of carcinogenesis and widely acknowledged that carcinogens in cigarette subsequent progression of lung cancer. In fact, smoke are deeply involved in these multiple genetic accumulating evidence points to the multi-step accu- alterations, mainly through the formation of DNA mulation of genetic and epigenetic changes, which adducts. A current understanding of the molecular often accompany the sequential morphological changes mechanisms of lung cancer pathogenesis and progres- (Figure 1). sion is presented in relation to cigarette smoking, an It is widely acknowledged that cigarette smoking is absolute major risk factor for lung cancer development, a dominant risk factor for lung cancer, and that by reviewing genetic alterations of various tumor carcinogens in the smoke are main initiators of lung suppressor genes and oncogenes thus far identified in cancer by inducing multiple genetic alterations, lung cancer, with brief summaries of their functions and mainly through the formation of DNA adducts. regulation. Fingerprints of such genetic insults can be seen, for Oncogene (2002) 21, 7421 – 7434. doi:10.1038/sj.onc. example, in the mutational spectra of p53 and KRAS. 1205802 Proper cell cycle regulation and checkpoints are crucial for maintaining genomic integrity, and their Keywords: tumor suppressor; oncogene; lung cancer abrogations are thought to contribute to genomic instability (Dhar et al., 2000), thereby playing an important role even in the early steps of cancer Introduction development. Many of the tumor suppressor genes and oncogenes altered in lung cancer are known to Lung cancer has become the leading cause of cancer play a role in the regulation of cell cycle progression death in many industrialized countries claiming more in either a direct or an indirect manner, and a than 160 000 and 50 000 lives annually in the United considerable proportion of the lung cancer-related States and Japan, respectively (Minna et al., 1997; genes are a component of the checkpoint mechan- Statistics and Information Department, Minister’s isms. In addition to the genetic and epigenetic Secretariat, 1999). A better understanding of the changes to genomic DNA, the presence of genetic molecular pathogenesis of this fatal disease is thus instability in lung cancer is also reflected by frequent urgently needed in order to achieve a preventive or structural and numerical changes of chromosomes therapeutic breakthrough aiming at a reduction in the (Testa, 1996; Haruki et al., 2001). In this study, we will mainly focus on the genetic changes, in relation to cigarette smoking, and their roles in the pathogen- *Correspondence: T Takahashi; E-mail: [email protected] esis and progression of lung cancer. Genetic alterations of lung cancer H Osada and T Takahashi 7422 Figure 1 Accumulation of alterations in the multi-step progression of lung carcinogenesis. Oncogenic triggering events, most sig- nificantly due to exposure to carcinogens in cigarette smoke, result in the accumulation of genetic and epigenetic alterations, which convert normal bronchial epithelium into hyperplastic, metaplastic and dysplastic lesions, and then carcinoma in situ (CIS) and overt squamous cell carcinomas. Adenocarcinoma is also thought to develop similarly in a multi-step fashion at least in part from pre-malignant lesions in the peripheral airways such as atypical adenomatous hyperplasia (AAH). Supposed biological consequences resulting from the genetic and epigenetic alterations are indicated Tumor suppressors and growth inhibitory signals components of checkpoints and growth inhibitory pathways as discussed below (Figure 2). During the processes of lung carcinogenesis and progression, multiple tumor-suppressor genes are p53/MDM2/p14ARF pathway (p53, 17p13.1; MDM2, inactivated. Alterations inactivating tumor suppressor 12q14.3-q15; p14ARF, 9p21) genes usually involve two events: deletion of a large chromosomal DNA segment of one allele and a smaller The p53 tumor suppressor gene is now regarded as a mutational or epigenetic event in the other allele. guardian of the genome, playing a central role in cell Previous studies on loss of heterozygosity (LOH) have cycle checkpoints. Upon damage of DNA in the provided clues to the localization of tumor suppressor genome, the ATM and ATR kinases are activated, genes involved in the pathogenesis. Deletions of 3p, resulting in the phosphorylation and consequential 9p21, 13q14, and 17p13 are frequently observed even in activation of the p53 protein directly at Ser 15 and the early lesions preceding the conversion into overt indirectly via CHK2 or CHK1 at Ser 20 (Figure 3). lung cancer. Allelic loss of 3p is among the most The activated p53 transactivates its target genes frequent and earliest events in lung cancer develop- including p21CIP/WAF1, 14-3-3s, BAX, and GADD45 ment, suggesting that an important tumor suppressor (Yu et al., 1999). Up-regulation of p21CIP1/WAF1 gene(s) may reside in this region. The 9p21, 13q14 and (Harper et al., 1993; el-Deiry et al., 1993) and 14-3-3s 17p13 regions harbor the p16INK4A/p14ARF/ (Hermeking et al., 1997) by p53 imposes G1 and G2 p15INK4B, Retinoblastoma (RB) and p53 genes, arrest, respectively, while the activated p53 is also inactivation of which has been shown to play a believed to participate in DNA repair through the fundamentally important role in the pathogenesis of induction of p53R2 expression (Yamaguchi et al., lung cancer. It is of note that these tumor suppressor 2001). Alternatively, unrepairable DNA damage may proteins compose functional linkages, i.e., p14ARF- lead to apoptotic cell death via p53-dependent p53 and p16INK4A-RB pathways, and that they are induction of the expression of various downstream Oncogene Genetic alterations of lung cancer H Osada and T Takahashi 7423 Figure 2 Alterations of tumor suppressor pathways in lung cancer. Two major pathways (i.e., p14ARF-p53 and p16INK4A-RB) involved in the pathogenesis of lung cancer are functionally linked and play roles as a component of checkpoints and growth in- hibitory pathways. In addition, signals from various oncogenes and growth factors are also linked to these pathways. Note that many of the components are inactivated in lung cancer. Molecules with frequent activating alterations in lung cancers are marked in red. Molecules showing frequent and infrequent inactivations are indicated in dark and light blue, respectively genes including the pro-apoptotic Bcl-2 family (BAX, resultant bulky DNA adducts, which are mainly NOXA,andPUMA) (Miyashita and Reed, 1995; Oda formed by carcinogens in cigarette smoke, preferen- et al., 2000a; Yu et al., 2001), APAF-1 (Robles et al., tially cause a guanine to thymine transversion. Highly 2001), PIG3 (Venot et al., 1998) and p53AIP (Oda et sensitive densitometric examination has revealed that al., 2000b). Phosphorylation at Ser 46 of the p53 smoking induces p53 mutations even in bronchial protein by HIPK2 has been suggested to play a key epithelial cells of normal morphological appearance role in the induction of apoptosis by p53 in concert (Hussain et al., 2001). In addition to a role for p53 with the phosphorylation of Ser15 and Ser20, described inactivation at the early stages of lung cancer above (D’Orazi et al., 2002; Hofmann et al., 2002). The development, accumulating evidence suggests a possi- regulation of centrosomal duplication has also been ble relation to a poor prognosis after surgical removal linked to p53 and its effecter p21CIP1 (Tarapore
Load more

Recommended publications
  • Tasmanian Devils' Transmissible Cancer
    Tasmanian devils’ transmissible cancer: Izarbe Aísa Marín Genetics Bachelor’s Degree What is the future? Final Project | June 2017 Introduction Devil Facial Tumor Disease 1Why is Tasmanian devils’ cancer incidence so high? 2Introduction to transmissible cancers Carcinogenesis is thought to occur via Peto’s Paradox represents the lack of accumulation of mutations and mutation correlation between cancer prevalence rates depend on cell number, which and body size or lifespan and it can be Primary Mode of Lack of Capacity for correlates with body size and lifespan. useful to explore cases that are far tumor’s origin transmission allorecognition infinite growth Then, large and long-lived animals from what is expected. Tasmanian should have more cancers than smaller devils suffer from Devil Facial Tumor and shorter-lived ones, due to increased Disease (DFTD), a lethal transmissible The ancestral type of DTDF is thought to be derived from a Schwann cell (clonal number of cell divisions. cancer that is threatening the species origin) and it is transmitted by biting during mating or feeding interactions. to extinction. (2) (1) y = 0,0815 - 0,0061x [y=%Tumors; x=Log(Mass[x]*LifeSpan[y])] 10x DFTD was first reported in Mount William National Park, northeastern Tasmania, in 1996. In 20 years, the disease has spread to more than 85% Forestier of wild Tasmanian devil Peninsula populations, causing severe declines. Immunology of DFTD 3Why devils immune system do not recognize DFTD? (3) Deficiency of devil Marsupials’ immune system is different immune system from, rather than inferior to mammals’ immune system. Immunological Low genetic Slower immune responses tolerance diversity facilitate early transmission events.
    [Show full text]
  • Principles of Cancer Prevention and Will Emphasize the Scientific Underpinnings of This Emerging Discipline
    Seminars in Oncology Nursing, Vol 21, No 4 (November), 2005: pp 229-235 229 OBJECTIVE: To summarize the scientific prin- ciples underlying cancer preven- tion. PRINCIPLES OF DATA SOURCES: Articles, text books, personal com- CANCER munications, and experience. CONCLUSION: PREVENTION The scientific basis of cancer pre- vention is complex and involves experimental and epidemiologic approaches and clinical trials. FRANK L. MEYSKENS,JR AND PATRICIA TULLY IMPLICATIONS FOR NURSING PRACTICE: ANCER prevention has classically encompassed As more information becomes three large areas of clinical practice: prevention, available regarding proven and screening, and early detection. Several excellent potential cancer-prevention strate- reviews and book chapters have been published gies, oncology nurses are regu- involving these topics.1-3 The importance of bio- larly called upon to guide patients Clogical and molecular markers as potential surrogates have been and others in making choices re- emphasized in the past several years,4,5 and more recently precan- garding preventative options. It is cers or intraepithelial neoplasia (IEN) have become a target.6,7 The important for oncology nurses to integration of the well-established approaches of prevention, stay abreast of this growing body screening, and early detection with biological measures of disease of knowledge. risk, progression, and prognosis has become the hallmark of mod- ern cancer prevention (see Fig 1). In this article we will review the principles of cancer prevention and will emphasize the scientific underpinnings of this emerging discipline. The principles of cancer prevention have evolved from three separate scientific disciplines: carcinogenesis, epidemiology, and clinical trials. Many other areas From the Department of Medicine and of science and medicine, including genetics and the behavioral Biological Chemistry, Chao Family Com- sciences, are contributing to this evolving and complex field.
    [Show full text]
  • Carcinogenesis
    Chapter 3 Chapter 3 Carcinogenesis CONTENTS Oral Carcinoma and Smokeless Tobacco Use: A Clinical Profile W. Frederick McGuirt and Anna Wray .................................................. 91 Introduction .................................................................................... 91 Patients ............................................................................................ 91 Field Cancerization ......................................................................... 92 Discussion........................................................................................ 93 References ........................................................................................ 95 Chemical Composition of Smokeless Tobacco Products Klaus D. Brunnemann and Dietrich Hoffmann ..................................... 96 Introduction .................................................................................... 96 Chemical Composition ................................................................... 97 Carcinogenic Agents in ST .............................................................. 97 Carcinogenic N-Nitrosamines ....................................................... 100 TSNA .............................................................................................. 101 Control of Carcinogens in ST ....................................................... 104 References ...................................................................................... 106 Carcinogenesis of Smokeless Tobacco Dietrich Hoffmann, Abraham
    [Show full text]
  • Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy
    cancers Review Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy Hadia Moindjie 1,2, Sylvie Rodrigues-Ferreira 1,2,3 and Clara Nahmias 1,2,* 1 Inserm, Institut Gustave Roussy, UMR981 Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800 Villejuif, France; [email protected] (H.M.); [email protected] (S.R.-F.) 2 LabEx LERMIT, Université Paris-Saclay, 92296 Châtenay-Malabry, France 3 Inovarion SAS, 75005 Paris, France * Correspondence: [email protected]; Tel.: +33-142-113-885 Simple Summary: Reprogramming metabolism is a hallmark of cancer. Warburg’s effect, defined as increased aerobic glycolysis at the expense of mitochondrial respiration in cancer cells, opened new avenues of research in the field of cancer. Later findings, however, have revealed that mitochondria remain functional and that they actively contribute to metabolic plasticity of cancer cells. Understand- ing the mechanisms by which mitochondrial metabolism controls tumor initiation and progression is necessary to better characterize the onset of carcinogenesis. These studies may ultimately lead to the design of novel anti-cancer strategies targeting mitochondrial functions. Abstract: Carcinogenesis is a multi-step process that refers to transformation of a normal cell into a tumoral neoplastic cell. The mechanisms that promote tumor initiation, promotion and progression are varied, complex and remain to be understood. Studies have highlighted the involvement of onco- genic mutations, genomic instability and epigenetic alterations as well as metabolic reprogramming, Citation: Moindjie, H.; in different processes of oncogenesis. However, the underlying mechanisms still have to be clarified. Rodrigues-Ferreira, S.; Nahmias, C. Mitochondria are central organelles at the crossroad of various energetic metabolisms.
    [Show full text]
  • Cancer Biology Introduction Proto-Oncogenes Tumor
    Introduction • Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell Cancer Biology death) of each of its constituent members except its stem cells • A tumor arises as a result of uncontrolled cell division and failure for self-elimination Chapter 18 • Alterations in three groups of genes are responsible Eric J. Hall., Amato Giaccia, for the deregulated control mechanisms that are the hallmarks of cancer cells: proto-oncogenes, tumor- Radiobiology for the Radiologist supressor genes, and DNA stability genes Proto-oncogenes Tumor-suppressor genes • Proto-oncogenes are components of signaling • Tumor-suppressor genes are also components of networks that act as positive growth the same signaling networks as proto-oncogenes, except that they act as negative growth regulators regulators in response to mitogens, cytokines, • They modulate proliferation and survival by and cell-to-cell contact antagonizing the biochemical functions of proto- • A gain-of-function mutation in only one copy oncogenes or responding to unchecked growth signals of a protooncogene results in a dominantly • In contrast to oncogenes, inactivation of both acting oncogene that often fails to respond to copies of tumor-suppressor genes is required for extracellular signals loss of function in most cases DNA stability genes Mechanisms of carcinogenesis • DNA stability genes form a class of genes • A single genetic alteration that leads to the involved in both monitoring and activation of an oncogene or loss of a tumor maintaining
    [Show full text]
  • A Guide to Cancer Immunotherapy: from T Cell Basic Science to Clinical Practice
    REVIEWS A guide to cancer immunotherapy: from T cell basic science to clinical practice Alex D. Waldman 1,2, Jill M. Fritz1,2 and Michael J. Lenardo 1,2 ✉ Abstract | The T lymphocyte, especially its capacity for antigen-directed cytotoxicity, has become a central focus for engaging the immune system in the fight against cancer. Basic science discoveries elucidating the molecular and cellular biology of the T cell have led to new strategies in this fight, including checkpoint blockade, adoptive cellular therapy and cancer vaccinology. This area of immunological research has been highly active for the past 50 years and is now enjoying unprecedented bench-to-bedside clinical success. Here, we provide a comprehensive historical and biological perspective regarding the advent and clinical implementation of cancer immunotherapeutics, with an emphasis on the fundamental importance of T lymphocyte regulation. We highlight clinical trials that demonstrate therapeutic efficacy and toxicities associated with each class of drug. Finally, we summarize emerging therapies and emphasize the yet to be elucidated questions and future promise within the field of cancer immunotherapy. Neoantigens The idea to deploy the immune system as a tool to treat system to prevent carcinogenesis in a manner similar to 1 1 Antigens not expressed by neoplastic disease originated in the nineteenth century . graft rejection . Productive immune responses following self-tissues under normal Wilhelm Busch and Friedrich Fehleisen were the first tumoural adoptive transfer in mice4 and clinical reports conditions that manifest in to describe an epidemiological association between of spontaneous regression of melanoma in patients with the context of pathology; in 5 cancer, these could be altered immune status and cancer.
    [Show full text]
  • Guidelines for Carcinogen Risk Assessment
    EPA/630/P-03/001B March 2005 Guidelines for Carcinogen Risk Assessment Risk Assessment Forum U.S. Environmental Protection Agency Washington, DC DISCLAIMER Mention of trade names or commercial products does not constitute endorsement or recommendation for use. CONTENTS 1. INTRODUCTION ........................................................ 1-1 1.1. PURPOSE AND SCOPE OF THE GUIDELINES ........................ 1-1 1.2. ORGANIZATION AND APPLICATION OF THE GUIDELINES ........... 1-3 1.2.1. Organization .............................................. 1-3 1.2.2. Application ............................................... 1-5 1.3. KEY FEATURES OF THE CANCER GUIDELINES ..................... 1-7 1.3.1. Critical Analysis of Available Information as the Starting Point for Evaluation ............................................... 1-7 1.3.2. Mode of Action ........................................... 1-10 1.3.3. Weight of Evidence Narrative ............................... 1-11 1.3.4. Dose-response Assessment .................................. 1-12 1.3.5. Susceptible Populations and Lifestages ........................ 1-13 1.3.6. Evaluating Risks from Childhood Exposures .................... 1-15 1.3.7. Emphasis on Characterization ............................... 1-21 2. HAZARD ASSESSMENT .................................................. 2-1 2.1. OVERVIEW OF HAZARD ASSESSMENT AND CHARACTERIZATION . 2-1 2.1.1. Analyses of Data ........................................... 2-1 2.1.2. Presentation of Results ...................................... 2-1 2.2.
    [Show full text]
  • Carcinogenesis and Chemotherapy—Cancer's Continuing Core Challenges: Third Charles Heidelberger Symposium1
    (CANCER RESEARCH 50. 7405-7409. November 15. 1990) Meeting Report Carcinogenesis and Chemotherapy—Cancer's Continuing Core Challenges: Third Charles Heidelberger Symposium1 Dr. Charles Heidelberger (1920-1983) devoted his entire delberger was able to attend the symposium and to share working life to cancer research and made outstanding contri memories of Charlie with us. butions in the areas of cancer chemotherapy and chemical carcinogenesis. According to his words (1), these parallel threads of research are "cancer's continuing core challenges." Keynote Lecture Dr. Heidelberger was a pioneer in the development of antime- The program of 38 scientific presentations was commenced tabolic drugs for the treatment of cancer. He introduced a with a keynote lecture given by Dr. T. Sugimura (National fluorine atom into uracil to produce 5-FU,2 a standard com Cancer Center, Tokyo, Japan) on "multiple genetic alterations during carcinogenesis." Dr. Sugimura summarized the multiple ponent of long standing, used in several protocols for the treatment of human solid cancers. His contributions to chemi genetic alterations observed in human cancers, which include cal carcinogenesis include the synthesis of radioactive polycyclic point mutations, rearrangements, sequence deletions, gene am aromatic hydrocarbons in the 1940s, the binding of polycyclic plification, and integration of viral genomes. Through these alterations, activation of oncogenes and inactivation of antion- aromatic hydrocarbons to cellular macromolecules in the 1950s cogenes occur, resulting in the acquisition of malignant phe- and 1960s, and the development of mammalian cell transfor mation in vitro in the C3H/10T'/2 cell line in the 1960s and notypes. Multiple genetic alterations are commonly found in many cancers, but the patterns of alterations vary depending 1970s.
    [Show full text]
  • Radiation Carcinogenesis
    Radiation Carcinogenesis November 22, 2016 Dhyan Chandra, Ph.D. Pharmacology and Therapeutics Roswell Park Cancer Institute Email: [email protected] Overview - History of radiation and radiation-induced damage - Bystander effect of radiation - Methods for DNA damage analysis - Stages of carcinogenesis and models - Mechanism of radiation-induced carcinogenesis - Role of oncogenes and tumor suppressors - Risk projections and risk estimates - Importance of dose and age on tumor incidence - Second malignancy after radiotherapy Radiation and cancer • 1895- Roentgen discovered X-rays • 1896- Henri Becquerel discovered radioactivity • 1897- Rutherford discovered α and β rays • 1898- Curies discovered polonium and radium • 1902- First report on radiation-induced skin cancer • 1911- First report of leukemia in 5 radiation workers Types of radiation Ionizing radiation: - α particles (2 protons and 2 neutrons) - β particles (electron equivalent) - Neutrons - Gamma rays - X-rays Non-ionizing radiation: - Microwaves - Visible light - Radio waves and TV waves - UV radiation (except shortest wavelengths) Units and doses Activity: Quantity of a radionuclide which describes the rate at which decays occur in an amount of a radionuclide. The SI unit of radioactivity is the becquerel (Bq), which replaced the old unit, the curie (Ci). Becquerel (Bq): One becquerel corresponds to 1 disintegration of a radionuclide per second. Curie (Ci): Old unit of radioactivity, corresponding to 3.7 x 1010 radioactive disintegrations per second Units and doses Absorbed dose (D): The energy imparted per unit mass by ionizing radiation to matter at a specific point. Gy: The SI unit of absorbed dose is joule per kilogram (J kg-1). The special name for this unit is gray (Gy).
    [Show full text]
  • Carcinogenesis: the Cancer Cell–Mast Cell Connection
    Inflammation Research (2019) 68:103–116 https://doi.org/10.1007/s00011-018-1201-4 Inflammation Research REVIEW Carcinogenesis: the cancer cell–mast cell connection Maria‑Angeles Aller1 · Ana Arias2 · Jose‑Ignacio Arias3 · Jaime Arias1 Received: 1 October 2018 / Revised: 14 November 2018 / Accepted: 14 November 2018 / Published online: 20 November 2018 © Springer Nature Switzerland AG 2018 Abstract Background In mammals, inflammation is required for wound repair and tumorigenesis. However, the events that lead to inflammation, particularly in non-healing wounds and cancer, are only partly understood. Findings Mast cells, due to their great plasticity, could orchestrate the inflammatory responses inducing the expression of extraembryonic programs of normal and pathological tissue formation. This heterogeneity of mast cells could allow a microenvironment to be recreated similar to the extraembryonic structures, i.e., amnion and yolk sac, which are needed for embryonic development. Mast cells could provide a framework for understanding the connection between inflammation and tumor growth, invasion and metastasis. In this way, the mast cells could express inflammatory phenotypes, which would enable the cancer stem cells to develop. Thus, the cancer cell uses mast cells to express the extraembryonic functions that are needed to allow the cancer stem cell to proliferate and invade. If so, then by using this appropriate inflammatory interstitial microenvironment, a cancer stem cell can reach maximum levels of growth and invasion inside the host. Conclusion Therefore, the comparison of tumors with wounds that do not heal would be supported since both pathological processes use extraembryonic mechanisms by mast cells. The adoption of these mechanisms warrants tumor survival in an embryonic-like state.
    [Show full text]
  • Role of Micrornas in Lung Carcinogenesis Induced by Asbestos
    Journal of Personalized Medicine Review Role of microRNAs in Lung Carcinogenesis Induced by Asbestos Rakhmetkazhy Bersimbaev *, Olga Bulgakova * , Akmaral Aripova, Assiya Kussainova and Oralbek Ilderbayev Department of General Biology and Genomics, Institute of Cell Biology and Biotechnology, L.N. Gumilyov Eurasian National University, Nur-Sultan 010008, Kazakhstan; [email protected] (A.A.); [email protected] (A.K.); [email protected] (O.I.) * Correspondence: [email protected] (R.B.); [email protected] (O.B.); Tel.: +7-7172-33-53-77 (R.B.); +7-707-432-97-27 (O.B.) Abstract: MicroRNAs are a class of small noncoding endogenous RNAs 19–25 nucleotides long, which play an important role in the post-transcriptional regulation of gene expression by targeting mRNA targets with subsequent repression of translation. MicroRNAs are involved in the patho- genesis of numerous diseases, including cancer. Lung cancer is the leading cause of cancer death in the world. Lung cancer is usually associated with tobacco smoking. However, about 25% of lung cancer cases occur in people who have never smoked. According to the International Agency for Research on Cancer, asbestos has been classified as one of the cancerogenic factors for lung cancer. The mechanism of malignant transformation under the influence of asbestos is associated with the genotoxic effect of reactive oxygen species, which initiate the processes of DNA damage in the cell. However, epigenetic mechanisms such as changes in the microRNA expression profile may also be implicated in the pathogenesis of asbestos-induced lung cancer. Numerous studies have shown that microRNAs can serve as a biomarker of the effects of various adverse environmental factors on the human body.
    [Show full text]
  • Chemical and Physical Carcinogenesis: Advances and Perspectives for the 1990S1
    [CANCER RESEARCH (SUPPL.) 51, 5023s-5044s, September 15. 1991] Chemical and Physical Carcinogenesis: Advances and Perspectives for the 1990s1 Curtis C. Harris2 Laboratory of Human Carcinogenesis, National Cancer Institute, N1H, Bethesda, Maryland 20892 Abstract the initiated cells with both an altered responsiveness to their microenvironment and moreover exerts a selective clonal ex Carcinogenesis is a multistage process driven by carcinogen-induced pansion advantage when compared to the surrounding normal genetic and epigenetic damage in susceptible cells that gain a selective cells (26-28). The initiated cells may have decreased respon growth advantage and undergo clonal expansion as the result of activation siveness to the inter- and intracellular signals that maintain of protooncogenes and/or inactivation of tumor suppressor genes. There fore, the mutational spectra of chemical and physical carcinogens in these normal tissue architecture and regulate the homeostatic growth critical genes are of interest to define endogenous and exogenous muta and maturation of cells. For example, initiated cells may be less tional mechanisms. The p53 tumor suppressor gene is ideally suited for responsive to negative growth factors, inducers of terminal cell analysis of the mutational spectrum. Such an analysis has revealed differentiation and/or programmed cell death (4, 26, 29-35). evidence for both exogenous and endogenous molecular mechanisms of Perturbation of the normal microenvironment by (a) physical Carcinogenesis. For example, an informative p53 mutational spectrum of means, e.g., wounding of the mouse skin or partial hepatectomy frequent G—»Ttransversions in codon 249 is found in hepatocellular carcinomas from either Qidong, People's Republic of China, or southern in rodents, (b) chemical agents, e.g., exposure of the mouse skin to certain phorbol esters or exposure of the rat liver to Africa.
    [Show full text]